Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation endomina® EZFuse system

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

EndoToolsTherapeutics

More Like This

Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System

Nitinotes Announces FDA IDE Approval to Initiate Pivotal U.S. Trial of the EndoZip™ System for Endoscopic Sleeve Gastroplasty

Endo Tools Therapeutics Appoints Devon Bream as Chief Executive Officer

Nitinotes Receives CE Mark Approval of EndoZip™, the First Fully Automated Suturing System for Endoscopic Sleeve Gastroplasty

Nitinotes Expands European Commercial Adoption with First Commercial EndoZip™ Cases Performed in France

Nitinotes Announces First Commercial EndoZip™ Procedures in Spain

Nitinotes Announces First Patient Treated in Pivotal EASE™ Clinical Trial Evaluating the EndoZip™ Automated Suturing System for ESG

PR Newswire associated0

Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial